Trump on Covid death toll: 'It is what it is'

Discussion in 'Coronavirus (COVID-19) News' started by MrTLegal, Aug 4, 2020.

  1. SEAL Team V

    SEAL Team V Banned

    Joined:
    Jul 27, 2019
    Messages:
    2,749
    Likes Received:
    3,559
    Trophy Points:
    113
    Gender:
    Male
    Don’t spew, post your findings by at least some half ass reputable findings. Otherwise all I hear from you is
     
  2. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    When I said, use "covidtracking.com," I was providing you with a link and a credible citation...did you need me to type in "www." for you as well?

    I am solely pointing out an assumption of your argument. Why do you need a citation?
     
  3. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    It is easier for me to quote the relevant experts that cite the double blind studies, but if you need links to the studies themselves - just let me know.

    Fauci, Birx Say Hydroxychloroquine Has No Benefit Against COVID-19, as Scientists Blast Study Touted by Trump
     
    Last edited: Aug 6, 2020
  4. drluggit

    drluggit Well-Known Member Donor

    Joined:
    Nov 17, 2016
    Messages:
    16,183
    Likes Received:
    13,174
    Trophy Points:
    113
    A website? So, if you have access to said website, it shouldn't be a stretch for you to actually glean the necessary information from said website that supports your justification. Do your work, it is the work you demand others do. Feel free.
     
  5. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    ...the **** are you going on about? I get that you think you are being clever or trying to point out some hypocrisy that you think I am exhibiting, but you are wrong.

    The number of tests is not synonymous with the number of individuals tested. For a very clear indication of what happens in the States where they made a switch, you can look to this recent report from Minnesota.

    "On July 30th, Minnesota reports again number of people tested. Due to this change, the number of total tests by Minnesota will decrease by 200,000. Number of specimens tested will still be tracked and available in our API."

    https://covidtracking.com/data/state/minnesota
     
  6. SEAL Team V

    SEAL Team V Banned

    Joined:
    Jul 27, 2019
    Messages:
    2,749
    Likes Received:
    3,559
    Trophy Points:
    113
    Gender:
    Male
    Good for Fauci, but there are 147.3 million people in 11 developed countries that state otherwise. Why is it that people in Costa Rica, Israel, Indonesia and 8 other countries are succumbing to COVID at less then 1/3 the rate of the US and other developed nations? Oh, I know. Their doctors are prescribing hydroxychloroquine.
    [​IMG]
    Many countries either adopted or declined early treatment with HCQ, forming
     
  7. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    You have got to be ******** me. When faced with five randomized and double blind studies, your response is a really weak ass attempt to use correlation from hcqtrials.com?

    Do not use HCQ unless your personal doctor recommends that you do so and, even then, consider getting a 2nd opinion.
     
    Last edited: Aug 6, 2020
    Quantum Nerd likes this.
  8. drluggit

    drluggit Well-Known Member Donor

    Joined:
    Nov 17, 2016
    Messages:
    16,183
    Likes Received:
    13,174
    Trophy Points:
    113
    You say write this, and it might even make logical sense to suggest it. It still doesn't absolve you of your own method here. You demand that others repeatedly provide you citations. And yet, here you are, waiving a web site as if that is the answer, which it isn't. So, you asserted a claim, it might sound reasonable, but you haven't supplied any substantive data that actually illuminates the extent to which your suggestion might otherwise support the attack on the data that was provided as not being credible. Do the work here. It is the standard you demand of others.
     
  9. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    "On July 30th, Minnesota reports again number of people tested. Due to this change, the number of total tests by Minnesota will decrease by 200,000. Number of specimens tested will still be tracked and available in our API."

    https://covidtracking.com/data/state/minnesota
     
  10. SEAL Team V

    SEAL Team V Banned

    Joined:
    Jul 27, 2019
    Messages:
    2,749
    Likes Received:
    3,559
    Trophy Points:
    113
    Gender:
    Male
    My response? Not a chance. How about the more then 100 responses from medical professionals that created that chart.
    References
    1.
    Academy of Medicine, Position Statement from the National Centre for Infectious Diseases and the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore – 23 May 2020,https://www.ams.edu.sg/view-pdf.as..tement+(final)+23-5-20+(logos).pdf.
    2.
    Acosta-Elias et al., Front. Pharmacol., 16 July 2020, doi:10.3389/fphar.2020.01062, The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection,https://www.frontiersin.org/articles/10.3389/fphar.2020.01062/full.
    3.
    Ahmad et al., doi:10.1101/2020.05.18.20066902, Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities,https://www.medrxiv.org/content/10.1101/2020.05.18.20066902v1.
    4.
    Alberici et al., Kidney Int., 98:1, 20-26, July 1, 2020, doi:10.1016/j.kint.2020.04.030 (preprint 5/10), A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection, https://www.kidney-international.o..cle/S0085-2538(20)30508-1/fulltext.
    5.
    An et al., medRxiv, doi:10.1101/2020.07.04.20146548, Treatment Response to Hydroxychloroquine and Antibiotics for mild to moderate COVID-19: a retrospective cohort study from South Korea,https://www.medrxiv.org/content/10.1101/2020.07.04.20146548v1.
    6.
    Andreani et al., Microbial Pathogenesis, doi:/10.1016/j.micpath.2020.104228, In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect,https://www.sciencedirect.com/science/article/pii/S0882401020305155.
    7.
    Arshad et al., Int. J. Infect. Dis., July 1 2020, doi:10.1016/j.ijid.2020.06.099, Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19,https://www.ijidonline.com/article/S1201-9712(20)30534-8/fulltext.
    8.
    Ashraf et al., medRxiv doi:10.1101/2020.04.20.20072421.t, COVID-19 in Iran, a comprehensive investigation from exposure to treatment outcomes,https://www.researchgate.net/publi..rom_exposure_to_treatment_outcomes.
    9.
    Ayerbe et al., Journal of Thrombosis and Thrombolysis, doi: 10.1007/s11239-020-02162-z, The association between treatment with heparin and survival in patients with Covid-19,https://doi.org/10.1101/2020.05.27.20114694.
    10.
    Barbosa et al., Preprint, Clinical outcomes of hydroxychloroquine in hospitalized patients with COVID-19: a quasi-randomized comparative study, https://bibliovid.org/en/clinical-..lized-patients-with-covid-19-a-302.
    11.
    BBC, India coronavirus: Nearly one in four in Delhi had Covid-19, study says, https://www.bbc.com/news/world-asia-india-53485039.
    12.
    Bernaola et al., medRxiv, doi:10.1101/2020.07.17.20155960,Observational Study of the Efficiency of Treatments in Patients Hospitalized with Covid-19 in Madrid,https://www.medrxiv.org/content/10.1101/2020.07.17.20155960v1.
    13.
    Bhattacharya et al., medRxix, doi:10.1101/2020.06.09.20116806, Pre exposure Hydroxychloroquine use is associated with reduced COVID19 risk in healthcare workers,https://www.medrxiv.org/content/10.1101/2020.06.09.20116806v1.
    14.
    Bo-gyung, K., The Korea Herald, Tests in recovered patients found false positives, not reinfections, experts say,http://www.koreaherald.com/view.php?ud=20200429000724.
    15.
    Borba et al., JAMA Network Open, doi:10.1001/jamanetworkopen.2020.8857, Chloroquine diphosphate in two different dosages as adjunctive therapy of hospitalized patients with severe respiratory syndrome in the context of coronavirus (SARS-CoV-2) infection: Preliminary safety results of a randomized, double-blinded, phase IIb clinical trial (CloroCovid-19 Study),https://www.medrxiv.org/content/10.1101/2020.04.07.20056424v2.
    16.
    Boulware et al., NEJM, June 3 2020, doi:10.1056/NEJMoa2016638, A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2016638.
    17.
    Bouza et al., Infect. Dis. Clin. North. Am., 2001 Jun, 15:2, 335-61, doi:10.1016/s0891-5520(05)70149-5, Infections in Systemic Lupus Erythematosus and Rheumatoid Arthritis,https://pubmed.ncbi.nlm.nih.gov/11447699/.
    18.
    Browning, D., Hydroxychloroquine and Chloroquine Retinopathy, April 4, 2014, 35–63, doi:10.1007/978-1-4939-0597-3_2, Pharmacology of Chloroquine and Hydroxychloroquine,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122276/.
    19.
    Brufsky, A., J. Medical Virology, doi:10.1002/jmv.25887,Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic,https://onlinelibrary.wiley.com/doi/full/10.1002/jmv.25887.
    20.
    Bultink et al., Rheumatology, doi:10.1093/rheumatology/keaa267,Mortality, causes of death and influence of medication use in patients with systemic lupus erythematosus vs matched controls,https://academic.oup.com/rheumatol...1093/rheumatology/keaa267/5870413.
    21.
    Carlucci et al., doi:10.1101/2020.05.02.20080036, Hydroxychloroquine and azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19 patients,https://www.medrxiv.org/content/10.1101/2020.05.02.20080036v1.
    22.
    Cavalcanti et al., NEJM, July 23, 2020, doi:10.1056/NEJMoa201901,Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2019014.
    23.
    CDC, Medicines for the Prevention of Malaria While Traveling Hydroxychloroquine (Plaquenil™),https://www.cdc.gov/malaria/resour..f/fsp/drugs/Hydroxychloroquine.pdf.
    24.
    CDC (B), Commercial Laboratory Seroprevalence Survey Data,https://www.cdc.gov/coronavirus/20..pdates/commercial-lab-surveys.html.
    25.
    Centers for Medicare and Medicaid Services, National Average Drug Acquisition Cost, https://data.medicaid.gov/Drug-Pri..t/NADAC-as-of-2019-08-07/m7ng-9e3x.
    26.
    Chamieh et al., medRxiv 2020.05.28.20114835, doi:10.1101/2020.05.28.20114835, Viral Dynamics Matter in COVID-19 Pneumonia: the success of early treatment with hydroxychloroquine and azithromycin in Lebanon,https://www.medrxiv.org/content/10.1101/2020.05.28.20114835v1.
    27.
    Chatterjee et al., Indian J. Med. Res., June 20, 2020, doi:10.4103/ijmr.IJMR_2234_20, Healthcare workers & SARS-CoV-2 infection in India: A case-control investigation in the time of COVID-19,http://www.ijmr.org.in/preprintarticle.asp?id=285520.
    28.
    Chen et al., medRxiv, doi:10.1101/2020.06.19.20136093, Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study,https://www.medrxiv.org/content/10.1101/2020.06.19.20136093v1.
    29.
    Chen (B) et al., medRxiv doi:10.1101/2020.03.22.20040758, Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial,https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v3.
    30.
    Chen (C) et al., J. Zhejiang University (Med Sci), doi:10.3785/j.issn.1008-9292.2020.03.03, A pilot study of hydroxychloroquine in treatment of patients with common coronavirus disease-19 (COVID-19),http://www.zjujournals.com/med/EN/..cleFile.do?attachType=PDF&id=41137.
    31.
    Chhonker et al., Journal of Chromatography B, Analytical Technologies in the Biomedical and Life Sciences, 22 Nov 2017, 1072:320-327 doi:10.1016/j.jchromb.2017.11.026 , Simultaneous quantitation of hydroxychloroquine and its metabolites in mouse blood and tissues using LC-ESI-MS/MS: An application for pharmacokinetic studies,https://europepmc.org/article/med/29207305.
    32.
    CIA, Obesity - Adult Prevalence Rate,https://www.cia.gov/library/public..d-factbook/rankorder/2228rank.html.
    33.
    Clementi et al., Front. Microbiol., 10 July 2020, doi:10.3389/fmicb.2020.01704 (preprint 3/31), Combined Prophylactic and Therapeutic Use Maximizes Hydroxychloroquine Anti-SARS-CoV-2 Effects in vitro,https://www.frontiersin.org/articl..ign=ECO_FCIMB_XXXXXXXX_auto-dlvrit.
    34.
    Cohen, M., NEJM, doi:10.1056/NEJMe2020388, Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence,https://www.nejm.org/doi/full/10.1056/NEJMe2020388.
    35.
    Colson et al., Int J. Antimicrob Agents, doi: 10.1016/j.ijantimicag.2020.105932. Epub 2020 Mar 4., Chloroquine and Hydroxychloroquine as Available Weapons to Fight COVID-19,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135139/.
    36.
    Covid19Crusher, Fake Hydroxychloroquine has appeared in Brazil,https://twitter.com/Covid19Crusher/status/1277526066152837122.
    37.
    Covid19Crusher (B), Marseille vs. Paris Death Statistics,https://twitter.com/Covid19Crusher/status/1278009960115376129.
    38.
    Covid19Crusher (C), https://twitter.com/Covid19Crusher.
    39.
    CovidAnalysis, Boulware et al. comments,https://c19study.com/boulware.html.
    40.
    D'Arminio Monforte et al., Int. J. Infectious Diseases, doi:10.1016/j.ijid.2020.07.056, Effectiveness of Hydroxychloroquine in COVID-19 disease: A done and dusted situation?,https://www.ijidonline.com/article/S1201-9712(20)30600-7/fulltext.
    41.
    Davido et al., Int. J. Antimicrobial Agents, 2020, doi:10.1016/j.ijantimicag.2020.106129, Impact of medical care including anti-infective agents use on the prognosis of COVID-19 hospitalized patients over time,https://www.sciencedirect.com/science/article/pii/S0924857920303125.
    42.
    Davido (B) et al., medRxiv, doi:10.1101/2020.05.05.2008875,Hydroxychloroquine plus azithromycin: a potential interest in reducing in hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?,https://www.medrxiv.org/content/10.1101
     
  11. SEAL Team V

    SEAL Team V Banned

    Joined:
    Jul 27, 2019
    Messages:
    2,749
    Likes Received:
    3,559
    Trophy Points:
    113
    Gender:
    Male
    42.
    Davido (B) et al., medRxiv, doi:10.1101/2020.05.05.2008875,Hydroxychloroquine plus azithromycin: a potential interest in reducing in hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)?,https://www.medrxiv.org/content/10.1101/2020.05.05.20088757v1.full.pdf.
    43.
    de Wilde et al., Antimicrobial Agents and Chemotherapy, Jul 2014, 58:8, 4875-4884, doi:10.1128/AAC.03011-14, Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture, https://aac.asm.org/content/58/8/4875.
    44.
    Derendorf, H., Int. J. Antimicrobial Agents, 7 May 2020, doi:10.1016/j.ijantimicag.2020.106007, Excessive lysosomal ion-trapping of hydroxychloroquine and azithromycin,https://www.sciencedirect.com/scie..e/pii/S0924857920301655?via%3Dihub.
    45.
    Derwand and Scholz, Medical Hypotheses, 142, doi:10.1016/j.mehy.2020.109815, Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?,https://www.sciencedirect.com/scie..e/pii/S0306987720306435?via%3Dihub.
    46.
    Devaux et al., International Journal of Antimicrobial Agents, doi:10.1016/j.ijantimicag.2020.105938, New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?,https://www.sciencedirect.com/science/article/pii/S0924857920300881.
    47.
    Eckerle et al., Lancet, July 6, 2020, doi:10.1016/S0140-6736(20)31482-3, SARS-CoV-2 seroprevalence in COVID-19 hotspots,https://www.thelancet.com/pdfs/jou..ancet/PIIS0140-6736(20)31482-3.pdf.
    48.
    Esper et al., Prevent Senior Institute, São Paulo, Brazil, Empirical treatment with hydroxychloroquine and azithromycin for suspected cases of COVID-19 followed-up by telemedicine,https://www.dropbox.com/s/5qm58cd4..20journal%20manuscript%20final.pdf.
    49.
    European University at St. Petersburg, 6% of People in St. Petersburg, Russia have had COVID-19, https://eusp.org/en/news/press-rel..ersburg-russia-have-had-covid-19-0.
    50.
    Ferreira et al., J. Medical Virology, July 9, 2020, doi:10.1002/jmv.26286 (preprint 6/29), Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection,https://www.medrxiv.org/content/10.1101/2020.06.26.20056507v1.
    51.
    Fitch, C., Trans. Am. Clin. Climatol. Assoc., 1997, 109:97-105, PMCID:pMC2194336, Involvement of heme in the antimalarial action of chloroquine, https://europepmc.org/article/med/9601131.
    52.
    Fontanet et al., medRxiv, 10.1101/2020.04.18.20071134, Cluster of COVID-19 in northern France: A retrospective closed cohort study,https://www.medrxiv.org/content/10.1101/2020.04.18.20071134v1.
    53.
    Fontanet (B) et al., medRxiv, doi:10.1101/2020.06.25.20140178, SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission,https://www.medrxiv.org/content/10.1101/2020.06.25.20140178v2.
    54.
    Gao et al., European Heart Journal, Volume 41, Issue 22, 7 June 2020, 2058–2066, doi:10.1093/eurheartj/ehaa433, Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study,https://academic.oup.com/eurheartj/article/41/22/2058/5851436.
    55.
    Gao (B) et al., BioScience Trends, 2020, doi:10.5582/bst.2020.01047,Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies,https://www.jstage.jst.go.jp/artic..dvpub/0/advpub_2020.01047/_article.
    56.
    Gao (C) et al., Biosci Trends, May 21, 2020, 14:2, 156-158, doi:10.5582/bst.2020.03072, Epub Apr 13, 2020, Update on Use of Chloroquine/Hydroxychloroquine to Treat Coronavirus Disease 2019 (COVID-19), https://pubmed.ncbi.nlm.nih.gov/32281583/.
    57.
    Gautret et al., Int. J. of Antimicrobial Agents, 17 March 2020, doi:10.1016/j.ijantimicag.2020.105949, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial, https://www.mediterranee-infection..roxychloroquine_final_DOI_IJAA.pdf.
    58.
    Gautret (B) et al., Travel Medicine and Infectious Disease, doi:10.1016/j.tmaid.2020.101663, Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study,https://www.sciencedirect.com/science/article/pii/S1477893920301319.
    59.
    Gebhard et al., Biol. Sex Differ., 2020, 11:29, doi:10.1186/s13293-020-00304-9, Impact of sex and gender on COVID-19 outcomes in Europe,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247289/.
    60.
    Geleris et al., NEJM, May 7, 2020, doi:10.1056/NEJMoa2012410,Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19, https://www.nejm.org/doi/full/10.1056/NEJMoa2012410.
    61.
    Gendelman et al., Autoimmunity Reviews, 19:7, July 2020, doi:10.1016/j.autrev.2020.102566, Continuous Hydroxychloroquine or Colchicine Therapy Does Not Prevent Infection With SARS-CoV-2: Insights From a Large Healthcare Database Analysis,https://www.sciencedirect.com/scie..e/pii/S1568997220301282?via%3Dihub.
    62.
    Giacomelli et al., medRxiv, doi:10.1101/2020.06.05.20123299, Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study,https://www.medrxiv.org/content/10.1101/2020.06.05.20123299v1.
    63.
    Guérin et al., Asian J. Medicine and Health, July 15, 2020, doi:10.9734/ajmah/2020/v18i730224 (preprint 5/31), Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19,https://www.preprints.org/manuscript/202005.0486/v1.
    64.
    Havers et al., JAMA Intern. Med., July 21, 2020, doi:10.1001/jamainternmed.2020.4130, Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020,https://jamanetwork.com/journals/j..ternalmedicine/fullarticle/2768834.
    65.
    Herrinton et al., J. Rheumatology, 2016, 43(8), doi:10.3899/jrheum,Risk of Serious Infection for Patients With Systemic Lupus Erythematosus Starting Glucocorticoids With or Without Antimalarials,https://pubmed.ncbi.nlm.nih.gov/27370880/.
    66.
    Hoffmann et al., Nature, (2020), doi:10.1038/s41586-020-2575-3,Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2, https://www.nature.com/articles/s41586-020-2575-3.
    67.
    Horby et al., medRxiv, 7/15/2020, doi:10.1101/2020.07.15.20151852 (press release 6/5), Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial,https://www.medrxiv.org/content/10.1101/2020.07.15.20151852v1.
    68.
    Howard et al., Preprints, doi:10.20944/preprints202004.0203.v1, Face Masks Against COVID-19: An Evidence Review,https://www.preprints.org/manuscript/202004.0203/v1.
    69.
    Hu et al., Nature Nanotechnology, 15, 247–249, 2020, doi:10.1038/s41565-020-0674-9, Insights from nanomedicine into chloroquine efficacy against COVID-19,https://www.nature.com/articles/s41565-020-0674-9.
    70.
    Huang et al., National Science Review, nwaa113, doi:10.1093/nsr/nwaa113, Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19,https://academic.oup.com/nsr/advan..le/doi/10.1093/nsr/nwaa113/5848167.
    71.
    Huang (B) et al., Journal of Molecular Cell Biology, Volume 12, Issue 4, April 2020, 322–325, doi:10.1093/jmcb/mjaa014, Treating COVID-19 with Chloroquine,https://academic.oup.com/jmcb/article/12/4/322/5814655.
    72.
    Iglay et al., Curr. Med. Res. Opin., July 2016, 32:7, 1243-52, doi:10.1185/03007995.2016.1168291, Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus,https://pubmed.ncbi.nlm.nih.gov/26986190/.
    73.
    Iliopoulos et al., Semin. Arthritis Rheum., 1996 Apr, 25(5):318-36,Immunopathogenesis and Spectrum of Infections in Systemic Lupus Erythematosus, https://pubmed.ncbi.nlm.nih.gov/8778988/.
    74.
    International Diabetes Federation, Diabetes Atlas, World Bank Diabetes Prevalence,https://data.worldbank.org/indicator/SH.STA.DIAB.ZS.
    75.
    Ioannidis, J., medRxiv, doi:10.1101/2020.05.13.20101253, The infection fatality rate of COVID-19 inferred from seroprevalence data,https://www.medrxiv.org/content/10.1101/2020.05.13.20101253v3.
    76.
    Ip et al., medRxiv, doi:10.1101/2020.05.21.20109207,Hydroxychloroquine and Tocilizumab Therapy in COVID-19 Patients - An Observational Study,https://www.medrxiv.org/content/10.1101/2020.05.21.20109207v1.
    77.
    Izoulet M., SSRN, doi:10.2139/ssrn.3575899, Countries which Primarily Use Antimalarial Drugs As COVID-19 Treatment See Slower Dynamic of Daily Deaths, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3575899.
    78.
    Jafari et al., Cell J. 2019, 20:4, 604–607, doi:10.22074/cellj.2019.5992,Why, When and How to Adjust Your P Values?,https://www.ncbi.nlm.nih.gov/pmc/a..s/PMC6099145/pdf/Cell-J-20-604.pdf.
    79.
    Jamil et al., medRxiv, doi:10.1101/2020.03.29.20046706, No evidence for temperature-dependence of the COVID-19 epidemic,https://www.medrxiv.org/content/10.1101/2020.03.29.20046706v2.
    80.
    Jiang et al., Chin. J. Tuberc. Respir. Dis., 2020, 43, doi:10.3760/cma.j.issn.1001-0939.2020.0019, Expert Consensus on Chloroquine Phosphate for the Treatment of Novel Coronavirus Pneumonia, http://rs.yiigle.com/yufabiao/1182323.htm.
     
  12. SEAL Team V

    SEAL Team V Banned

    Joined:
    Jul 27, 2019
    Messages:
    2,749
    Likes Received:
    3,559
    Trophy Points:
    113
    Gender:
    Male
    81.
    Kamran et al., medRxiv, doi:10.1101/2020.07.30.20165365, Clearing the fog: Is HCQ effective in reducing COVID-19 progression: A randomized controlled trial,https://www.medrxiv.org/content/10.1101/2020.07.30.20165365v1.
    82.
    Keyaerts et al., Biochem. Biophys. Res. Comm., 323:1, 8 October 2004, doi:10.1016/j.bbrc.2004.08.085, In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine,https://www.sciencedirect.com/science/article/pii/S0006291X0401839X.
    83.
    Keyaerts (B) et al., Antimicrob. Agents Chemother, August 2009, 53(8), doi:0.1128/AAC.01509-08, Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715625/.
    84.
    Khurana et al., medRxiv, doi:10.1101/2020.07.21.20159301, Prevalence and clinical correlates of COVID-19 outbreak among healthcare workers in a tertiary level hospital,https://www.medrxiv.org/content/10.1101/2020.07.21.20159301v1.
    85.
    Kim et al., medRxiv, doi:10.1101/2020.05.13.20094193, Treatment Response to Hydroxychloroquine, Lopinavir/Ritonavir, and Antibiotics for Moderate COVID 19: A First Report on the Pharmacological Outcomes from South Korea,https://www.medrxiv.org/content/10.1101/2020.05.13.20094193v1.
    86.
    Kim (B) et al., Rheumatology (Oxford), 2018 Jul, 57:26–33, doi: 10.1093/rheumatology/kex523, Risk of human papillomavirus infection in women with rheumatic disease: cervical cancer screening and prevention, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099129/.
    87.
    Kono et al., Antiviral Research, 77:2, February 2008, 150-152, 10.1016/j.antiviral.2007.10.011, Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: Involvement of p38 MAPK and ERK,https://www.sciencedirect.com/science/article/pii/S0166354207004597.
    88.
    Kucirka et al., Annals of Internal Medicine, doi:10.7326/M20-1495,Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure,https://www.acpjournals.org/doi/10.7326/M20-1495.
    89.
    Lagier et al., Travel Med. Infect. Dis. 101791, Jun 25, 2020, doi:10.1016/j.tmaid.2020.101791, Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis,https://www.sciencedirect.com/science/article/pii/S1477893920302817.
    90.
    Lee at al., Int. J. Antimicrob. Agents, 2020, Apr 17, doi:10.1016/j.ijantimicag.2020.105988, Can Post-Exposure Prophylaxis for COVID-19 Be Considered as an Outbreak Response Strategy in Long-Term Care Hospitals?, https://pubmed.ncbi.nlm.nih.gov/32305587/.
    91.
    Leffler et al., Preprint, Association of country-wide coronavirus mortality with demographics, testing, lockdowns, and public wearing of masks (Update June 15, 2020),https://www.researchgate.net/publi..aring_of_masks_Update_June_15_2020.
    92.
    Lewis, N., Climate Etc., The progress of the COVID-19 epidemic in Sweden: an analysis, https://judithcurry.com/2020/06/28..19-epidemic-in-sweden-an-analysis/.
    93.
    Li et al., Ann. Rheum. Dis, 2019 Jul, 78:7, 941-946, doi:10.1136/annrheumdis-2018-214844, Risk of Severe Herpes Simplex Virus Infection in Systemic Lupus Erythematosus: Analysis of Epidemiology and Risk Factors Analysis in Taiwan,https://pubmed.ncbi.nlm.nih.gov/30954968/.
    94.
    Listing et al., Rheumatology (Oxford), 2013 Jan, 5:1, 53-61, doi:10.1093/rheumatology/kes305, The Risk of Infections Associated With Rheumatoid Arthritis, With Its Comorbidity and Treatment,https://pubmed.ncbi.nlm.nih.gov/23192911/.
    95.
    Liu et al., Cell Discovery 6, 16 (2020), doi:10.1038/s41421-020-0156-0,Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro,https://www.nature.com/articles/s41421-020-0156-0.
    96.
    Macias et al., medRxiv, 10.1101/2020.05.16.20104141, Similar incidence of Coronavirus Disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy,https://www.medrxiv.org/content/10.1101/2020.05.16.20104141v1.full.pdf.
    97.
    Magagnoli et al., Med (2020), doi:10.1016/j.medj.2020.06.001 (preprint 4/21), Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19, https://www.cell.com/med/pdf/S2666-6340(20)30006-4.pdf.
    98.
    Mahévas et al., BMJ 2020, 369, doi: https://doi.org/10.1136/bmj.m1844, Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data,https://www.bmj.com/content/369/bmj.m1844.
    99.
    Maisonnasse et al., Nature, 2020, doi:10.1038/s41586-020-2558-4 (preprint 5/6), Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates, https://www.nature.com/articles/s41586-020-2558-4_reference.pdf.
    100.
    Maret W., Int. J. Mol. Sci. 2017, 18:11, doi:10.3390/ijms18112285, Zinc in Cellular Regulation: The Nature and Significance of “Zinc Signals”,https://www.mdpi.com/1422-0067/18/11/2285.
    101.
    McLean et al., Open Forum Infect. Dis. September 2015, 2:3, doi:10.1093/ofid/ofv100, Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/.
    102.
    Mehra et al., The Lancet, May 22, 2020, doi: 10.1016/S0140-6736(20)31180-6, Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis,https://www.thelancet.com/journals../PIIS0140-6736(20)31180-6/fulltext.
    103.
    Membrillo de Novales et al., Preprints 2020, 2020050057, doi:10.20944/preprints202005.0057.v1, Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19 Patients: An Observational Study,https://www.preprints.org/manuscript/202005.0057.
    104.
    Meo et al., Eur. Rev. Med. Pharmacol. Sci. 2020, 24 (8), 4539-4547, doi:10.26355/eurrev_202004_21038, Efficacy of chloroquine and hydroxychloroquine in the treatment of COVID-19,https://www.europeanreview.org/article/21038.
    105.
    Mikami et al., J. Gen. Intern. Med., doi:10.1007/s11606-020-05983-z,Risk Factors for Mortality in Patients with COVID-19 in New York City,https://link.springer.com/article/10.1007/s11606-020-05983-z.
    106.
    Million et al., Travel Med Infect Dis., 2020 May 5, doi:10.1016/j.tmaid.2020.101738, Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin: A Retrospective Analysis of 1061 Cases in Marseille, France,https://pubmed.ncbi.nlm.nih.gov/32387409/.
    107.
    Mills et al., Circulation, Aug 9, 2016, 134:6, 441–450, doi:10.1161/circulationaha.115.018912, Global Disparities of Hypertension Prevalence and Control: A Systematic Analysis of Population-based Studies from 90 Countries,https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979614/.
    108.
    Mitchell, G., SSRN Preprint, June 16, 2020, doi:10.2139/ssrn.3628644,A Tale of Two Cities – Lagos, Nigeria’s Apparent Success in the War Against COVID-19, https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3628644.
    109.
    Mitjà et al., medRxiv, doi:10.1101/2020.07.20.20157651, A Cluster-Randomized Trial of Hydroxychloroquine as Prevention of Covid-19 Transmission and Disease,https://www.medrxiv.org/content/10.1101/2020.07.20.20157651v1.
    110.
    Mitjà (B) et al., Clinical Infectious Diseases, ciaa1009, doi:10.1093/cid/ciaa1009, Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial,https://academic.oup.com/cid/artic..a1009/5872589#.XxCYlMdGoJM.twitter.
    111.
    Molina et al., Médecine et Maladies Infectieuses, 50:4, June 2020, 10.1016/j.medmal.2020.03.006 (preprint 3/28), No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection,https://www.sciencedirect.com/science/article/pii/S0399077X20300858.
    112.
    NIH, Zinc Fact Sheet for Health Professionals,https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/.
    113.
    Olza et al., Nutrients 2017, 9:7, 697, doi:10.3390/nu9070697, Reported Dietary Intake and Food Sources of Zinc, Selenium, and Vitamins A, E and C in the Spanish Population: Findings from the ANIBES Study,https://www.mdpi.com/2072-6643/9/7/697.
    114.
    Otea et al., medRxiv, doi:10.1101/2020.06.10.20101105, A short therapeutic regimen based on hydroxychloroquine plus azithromycin for the treatment of COVID-19 in patients with non-severe disease. A strategy associated with a reduction in hospital admissions and complications.,https://www.medrxiv.org/content/10.1101/2020.06.10.20101105v1.
    115.
    Our World in Data, Data on COVID-19 (coronavirus) by Our World in Data, https://github.com/owid/covid-19-data/tree/master/public/data.
    116.
    Our World in Data (B), Life Expectancy, https://ourworldindata.org/life-expectancy.
    117.
    Our World in Data (C), Total COVID-19 tests per 1,000 people,https://ourworldindata.org/grapher..total-tests-per-thousand-bar-chart.
    118.
    Our World in Data (D), Population Density,https://ourworldindata.org/grapher/population-density.
    119.
    Our World in Data (E), Coronavirus Source Data,https://ourworldindata.org/coronavirus-source-data.
    120.
    Our World in Data (F), COVID-19: Government Response Stringency Index, https://ourworldindata.org/grapher/covid-stringency-index.
    121.
    Paccoud et al., Clinical Infectious Diseases, doi:10.1093/cid/ciaa791,Compassionate use of hydroxychloroquine in clinical practice for patients with mild to severe Covid-19 in a French university hospital,https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa791/5859555.
    122.
    Pagliano et al., Clin. Infect. Dis., 2020 Mar 24, doi:10.1093/cid/ciaa320,Is Hydroxychloroquine a Possible Post-Exposure Prophylaxis Drug to Limit the Transmission to Health Care Workers Exposed to COVID19?,https://pubmed.ncbi.nlm.nih.gov/32211764/.
    123.
    Pirnay et al., Hosp. Pharm. and Clinician, doi:10.1016/j.phclin.2020.06.001, Beneficial effect of Hydroxychloroquine-Azithromycin combination in the treatment of elderly patients with Covid-19: results of an observational study,https://www.sciencedirect.com/science/article/pii/S2211104220300771.
    124.
    Public Health England, Sero-surveillance of COVID-19,https://www.gov.uk/government/publ..orts/sero-surveillance-of-covid-19.
    125.
    Rafaeli, F., Medium, July 23, 2020, Hydroxychloroquine: The Narrative That it Doesn’t Work is the Biggest Hoax in Recent Human History,https://truthabouthcq.com/hcq-works/.
    126.
    Risch, H., American Journal of Epidemiology, July 20, 2020, doi:10.1093/aje/kwaa152, Response to: “Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients” and “Re: Early Outpatient Treatment of Symptomatic, High-Risk Covid-19 Patients that Should be Ramped-Up Immediately as Key to the Pandemic Crisis”,https://academic.oup.com/aje/article/doi/10.1093/aje/kwaa152/5873640.

    And there’s hundreds more doctor’s studies that back the claim of hydroxychloroquine helps COVID19 patients.
     
    Last edited: Aug 6, 2020
  13. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    Just to highlight a few of your "sources."

    Why are drug acquisition costs, adult obesity prevalence rates, or the notion that fake HCQ is showing up in Brazil proof to you?
     
    Last edited: Aug 6, 2020
  14. Statistikhengst

    Statistikhengst Well-Known Member

    Joined:
    Oct 8, 2015
    Messages:
    7,818
    Likes Received:
    8,202
    Trophy Points:
    113
    Gender:
    Male
    Because there is no reason to bring it up until the statistics are finished. This is, for better or worse, a work in progress. And India has just now began to ramp up its testing - it is months behind the USA in that regard.

    Comprehension is not your friend, but trolling apparently is.
     
    Last edited: Aug 7, 2020
    MrTLegal likes this.
  15. GlobalCitizen

    GlobalCitizen Well-Known Member

    Joined:
    Aug 28, 2013
    Messages:
    5,435
    Likes Received:
    144
    Trophy Points:
    63
    REPORTER: "This week Americans lost 6-7k people during the taking of Iwo Jima. How confident are you in the ultimate success of our current island hopping strategy, and what will "success" look like?"

    FDR: "It is what it is..."

    Yeah that would have been stellar leadership.
     
    Last edited: Aug 7, 2020
    Quantum Nerd likes this.
  16. fmw

    fmw Well-Known Member

    Joined:
    Aug 21, 2009
    Messages:
    15,349
    Likes Received:
    5,148
    Trophy Points:
    113
    Or an honest answer.
     
  17. Quantum Nerd

    Quantum Nerd Well-Known Member

    Joined:
    Nov 14, 2014
    Messages:
    10,615
    Likes Received:
    8,405
    Trophy Points:
    113
    An honest answer would have been to see eye to eye with the American people on the severity of this pandemic, not to pretend from day one that it is under control and will go away soon.
     
  18. drluggit

    drluggit Well-Known Member Donor

    Joined:
    Nov 17, 2016
    Messages:
    16,183
    Likes Received:
    13,174
    Trophy Points:
    113
    Translation... why, you are correct, but it makes my previous post look less credible.... And now, there are excuses..... Got it.
     
  19. drluggit

    drluggit Well-Known Member Donor

    Joined:
    Nov 17, 2016
    Messages:
    16,183
    Likes Received:
    13,174
    Trophy Points:
    113
    And yet, a reporter never asked a question like that of FDR. And had one asked, at that time of FDR, their future housing might not have been very comfortable....

    What magic bean did you expect the president to offer up? For that matter, why aren't the reporting class asking folks like Fauci those same questions? And when he responds with useless doublespeak, why aren't you this concerned? When Andy sent sick folks to the nursing homes to die, which reporter asked Andy why, or how successful his death rates were? And why didn't he get asked?
     
  20. Quantum Nerd

    Quantum Nerd Well-Known Member

    Joined:
    Nov 14, 2014
    Messages:
    10,615
    Likes Received:
    8,405
    Trophy Points:
    113
    What magic bean? For starters:
    -Being honest with the American people about the severity of the crisis
    -Showing compassion with the ones who passed away, and their families
    -Being realistic about the failures of the efforts to contain the virus
    -Having a realistic plan for future pandemic management, instead of blowing rose-colored smoke
     
    MJ Davies and FoxHastings like this.
  21. drluggit

    drluggit Well-Known Member Donor

    Joined:
    Nov 17, 2016
    Messages:
    16,183
    Likes Received:
    13,174
    Trophy Points:
    113
    Hmm.. so, basically be a democrat? Is that what has to always happen? Just some perspective here. Realistically, what do you expect a president to do? Would you favor say the use of marshal law? Would that be an effective containment strategy? Would that demonstrate his level of honesty and recognition of the severity of the crisis you describe? As for the "realistic plan", what does that even mean? Who would means test the plan? you?

    Folks have died. Yup. It's sad. Totally. This happens, periodically. And yet, I still haven't seen you, or most folks of the left cry out against the cause of the virus being 1) engineered, 2) developed at the behest of the previous administration 3) developed in a lab with inadequate safeguards, 4) inadequate safeguards leading to it being released, 5) failure of the Chinese government to contain it while they could have, etc. And when folks, like me, bring this up, you folks run away telling us that we're conspirators... you know, against "china", or some other toss....

    At this point, given the inability of the medical community to effectively develop either a cure, or a treatment, what do you want the guy to say? What can he say?
     
  22. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    "I have failed those dead Americans" is also an honest answer for donald trump.
     
    Quantum Nerd likes this.
  23. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    A **** translation is a **** argument.
     
    Quantum Nerd likes this.
  24. MrTLegal

    MrTLegal Banned

    Joined:
    Feb 25, 2017
    Messages:
    41,094
    Likes Received:
    26,652
    Trophy Points:
    113
    Dr. Fauci was asked this week by Sanjay Gupta, "Did we let the American people down" with our "failed response?"

    Fauci's response:
    “Sanjay, you know if I make the statement that we let the American people down it would be distracting because that would be the sound bite and I wouldn’t want to get the message that I’m trying to get across, where I think we can handle this if we have some fundamental principles that I hope and I know you’ll let me get the opportunity to articulate, because we can do much better, and we can do much better without locking down,” Fauci responded.

    Fauci faulted the binary approach that some states took regarding a lockdown and noted that the goal should be to find a place in the middle, which would eliminate surges without leading to a complete economic crisis.


    https://www.mediaite.com/tv/dr-sanj...onavirus-did-we-let-the-american-people-down/
     
    MJ Davies likes this.
  25. Quantum Nerd

    Quantum Nerd Well-Known Member

    Joined:
    Nov 14, 2014
    Messages:
    10,615
    Likes Received:
    8,405
    Trophy Points:
    113
    Ah, being honest, compassionate and realistic are Democrat traits? Who would have known..
     
    Last edited: Aug 7, 2020
    MrTLegal likes this.

Share This Page